In the context of growing political polarization, the debate of what should be the role of the state in funding research and development represents a particularly relevant and engaging question within the broader political arena.
At one extreme, the statist viewpoint advocates for stronger government intervention in research and development to drive progress and societal welfare, addressing global societal needs and providing resources for fundamental research that has no immediate use. On the opposing end, the libertarian perspective points to the immoral nature of tax-based funding and upholds individual freedom, defending minimal government intrusion and highlighting the potential of private-sector initiatives.
Analyzing the arguments from these two contrasting worldviews can help develop a critical opinion of the value and role of research and development in society, and reflect how to achieve the right balance to maximise or optimize the use of funds and the potential for societal progress.
As mentioned, the case against government funding from the libertarian point of view stems from the individual’s right to engage in transactions voluntarily. Given that government funding for research and development comes from taxation and this is based on a forced redistribution of wealth without individual consent, any use of that money is immoral. It is not enough to look at how many lives could be potentially saved by a newly discovered drug, how much an invention could help mitigate climate change consequences, or how many jobs could be created by a new and promising start-up, the end does not justify the means.
Libertarians would also contend that government-funded programs are prone to inefficiency and misallocation, as well as the creation of unnecessary bureaucratic structures and stifling state dependencies. State funding decisions may not be guided by the most efficient resource allocation mechanisms but by political agendas that skew decisions toward building political capital for the next election. Without a state, individual initiatives would be encouraged and market competition would align the research and innovation agenda with the individual’s needs and wishes. Together with investors, private research and innovation organizations would then emerge to address those demands and develop innovative solutions.
In favour of this position, it is easy to identify private investors that showed a long-term commitment to funding high-risk initiatives to which society assigned high rewards, or private companies that have been instrumental in propelling a widespread use of new technologies. Also, private philanthropic initiatives have demonstrated alternative approaches to address global health and climate issues without influencing political priorities.
In contrast, proponents of government funding highlight the capacity of state intervention to counterbalance and complement the market’s shortcomings, especially in fundamental long-term and high-risk research areas. These may not have commercial interest but can push the frontiers of knowledge and technological development. Not only can public funding help overcome market gaps but it can also play a pivotal role in sparking and directing massive scientific endeavours that no single private investor, company or even country could organize given their complexity and costs.
Defendants of state investment would also contend that by derisking the viability of certain areas of research or technologies, the government is stimulating the involvement of the private sector and accelerating the development and uptake of new technologies. They would also assert that the risk of political influence on the research agendas can be managed through transparent, accountable and peer-reviewed processes involving diverse experts. Careful planning and oversight of research priorities or grants can also help ensure their alignment with societal needs and values, so priorities are not solely dictated by market demand or profit motives.
To showcase the benefits of these public investments, one can quickly find examples of emerging technologies that have been developed with public funding through their earliest and riskiest stages, state leadership in big science and ambitious initiatives, and plenty of governmental programs that are the backbone of research and development needed to address some of our most urgent challenges.
Generally, the current way to bypass the dichotomy between these seemingly exclusive funding approaches is to have both play a synergistic role across different stages of the research and development value chain, each playing at its strengths. However, this does not fully address the dilemma.
It is still important, to find an efficacious and fair balance, to have the right incentives and rewards for the different stakeholders, as well as to have the right opt-in and decision-making mechanisms in place for citizens to influence the knowledge creation and transfer process.
It is also important to consider that besides the role that the public and private sectors play in funding new research and development, it is also important to consider their role in the final stages of development and use of the new knowledge generated.
For instance, it could be argued that the public sector lags significantly behind the private sector in the early adoption and validation of the resulting innovations. At the same time, some claim that the private sector cashes out excessively from technologies that were highly derisked with public funding. These further exemplify the complexity of addressing the multifaceted dilemma of state funding.